WFDC2 and neoplasm: Patients with an observed tumour invasion of ≥1⁄2 of the myometrium, uterine serosal invasion, or cervical stromal invasion, and simultaneously with HE4 ≥ 103 pmol/L were clearly classified as high-risk.